We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HEPA market cap is 1.48M. The company's latest EPS is USD -1.2019 and P/E is -0.11.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.41M | -5.18M | -8.5M | -4.46M | -1.2M |
| Net Income | -11.06M | -2.85M | -3.93M | -4.87M | -1.55M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.15M | -30.4M | -45.49M | -48.45M | -19.35M |
| Net Income | -20.36M | -32.72M | -45.34M | -48.93M | -13.19M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 18.09M | 15.99M | 6.01M | 3.72M | 1.61M |
| Total Liabilities | 10.81M | 8.47M | 2.45M | 4.12M | 3.48M |
| Total Equity | 7.28M | 7.52M | 3.56M | -406k | -1.86M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 48.65M | 103.55M | 60.24M | 18.09M | 1.61M |
| Total Liabilities | 8.13M | 10.56M | 10.39M | 10.81M | 3.48M |
| Total Equity | 40.52M | 93M | 49.86M | 7.28M | -1.86M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -40.89M | -3.62M | -14.55M | -17.06M | -18.22M |
| Investing | -14k | N/A | N/A | -600k | -600k |
| Financing | 4.5M | 1.85M | 1.85M | 4.35M | 4.35M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -16.17M | -31.22M | -34.96M | -40.89M | -18.22M |
| Investing | -86k | -131k | -14k | -14k | -600k |
| Financing | 43.06M | 81.98M | -5.14M | 4.5M | 4.35M |
| Market Cap | 1.48M |
| Price to Earnings Ratio | -0.11 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.51 |
| Price to Book Ratio | -0.77 |
| Dividend Yield | - |
| Shares Outstanding | 10.98M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -99.77% |
| 52 Week High | 59.75 |
| 52 Week Low | 0.1081 |
| Spread (Intraday) | 0.01 (6.92%) |
| Company Name | Hepion Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.hepion.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
